A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2

NCT06931028 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Apnea
Obstructive
Obesity

Interventions

OTHER: placebo
DRUG: IBI362

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.